Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cutaneous mesenchymal tumours: an update.Pathology. 2014; 46: 149-159
- Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate.J Clin Oncol. 2005; 23: 7669-7675
- Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up.Am J Surg Pathol. 2000; 24: 1125-1130
- Dermatofibrosarcoma.Protuberans Cancer. 2004; 101: 2503-2508
- WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3; 100-103). https://publications.iarc.fr/588..Soft Tissue and Bone Tumours. 2020;
- Website. Website. 13. National Comprehensive Cancer Network. Dermatofibrosarcoma Protuberans (Version 1.2020).(Avaiable at:) (Accessed Sept 10, 2021)
- Watch and wait approach for re-excision after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and does not affect metastatic risk or amputation rate.Ann Surg Oncol. 2019; 26: 3526-3534
- Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2021; 32: 1348-1365
- Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.Eur J Cancer. 2015; 51: 2604-2608
- Margins in DFSP Reconsidered: Primum Non Nocere.Ann Surg Oncol. 2020; 27: 634-636
- The role of radiation therapy in the management of dermatofibrosarcoma protuberans.Int J Radiat Oncol Biol Phys. 1998; 40: 823-827
- Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.Clin Cancer Res. 2014; 20: 499-510
- Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?.Cancer. 2019; 125: 735-741
- Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007.Ann Diagn Pathol. 2011; 15: 93-97
- Cutaneous angiosarcoma of the scalp: a multidisciplinary approach.Cancer. 2003; 98: 1716-1726
- Sarcoma of the breast: an update on a rare entity.J Clin Pathol. 2016; 69: 373-381
- Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp.Head Neck. 2011; 33: 661-667
- Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature.Br J Cancer. 2004; 91: 237-241
- Treatment and outcome of 82 patients with angiosarcoma.Ann Surg Oncol. 2007; 14: 1953-1967
- An analysis of 78 breast sarcoma patients without distant metastases at presentation.Int J Radiat Oncol Biol Phys. 2000; 46: 383-390
- Treatment and outcomes of patients with primary breast sarcoma.Am J Surg. 2008; 196: 559-561
- Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience.Surgery. 1994; 116: 505-509
- Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica.Cancer. 1948; 1: 64-81
- Long-term risk of sarcoma following radiation treatment for breast cancer.Int J Radiat Oncol Biol Phys. 1991; 21: 361-367
- Post-treatment sarcoma in breast cancer patients.Ann Surg Oncol. 1994; 1: 66-72
- Stewart-treves syndrome: a case report and review of the literature.Case Rep Oncol. 2016; 9: 205-211
- Lymphangiosarcoma arising in chronic lymphedematous extremities.Cancer. 1972; 30: 562-572
- Role of surgery in the management of postmastectomy extremity angiosarcoma (Stewart-Treves syndrome).J Surg Oncol. 2000; 73: 182-188
- Post-mastectomy lymphangiosarcoma (Stewart-Treves syndrome): report of two long-term survivals.Br J Radiol. 1991; 64: 857-860
- Isolated limb perfusion for locally advanced angiosarcoma in extremities: A multi-centre study.Eur J Cancer. 2017; 85: 114-121
- Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable sSewart-Treves lymphangiosarcoma.Ann Surg Oncol. 2002; 9: 1004-1009
- Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network.Radiother Oncol. 2007; 85: 355-361
- Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.Am J Surg Pathol. 2012; 36: 1317-1326
- Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases.Am J Dermatopathol. 2010; 32: 533-540
- Atypical fibroxanthoma and pleomorphic dermal sarcoma: a reappraisal.J Cutan Pathol. 2021; 48: 207-210
- Conception and management of a poorly understood spectrum of dermatologic neoplasms: atypical fibroxanthoma, pleomorphic dermal sarcoma, and undifferentiated pleomorphic sarcoma.Curr Treat Options Oncol. 2017; 18: 50
- More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?.Dermatol Surg. 2009; 35: 765-772
- TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.Mod Pathol. 2014; 27: 502-508
- Atypical Fibroxanthoma: the washington university experience.Dermatol Surg. 2019; 45: 1450-1458
- Integrative analysis of pleomorphic dermal sarcomas reveals fibroblastic differentiation and susceptibility to immunotherapy.Clin Cancer Res. 2020; 26: 5638-5645
- Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group.Cancer. 2007; 109: 282-291
- Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases.Histopathology. 2010; 56: 251-262
- Cutaneous leiomyosarcoma: dermal and subcutaneous.Australas J Dermatol. 2020; 61: 243-249
- Treatment outcome of superficial leiomyosarcoma.J Surg Oncol. 2021; 123: 127-132
- Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous “leiomyosarcoma.Am J Surg Pathol. 2011; 35: 599-607
- Primary leiomyosarcoma of the skin: a comprehensive review on diagnosis and treatment.Med Oncol. 2018; 35: 135
Article info
Publication history
Published online: May 31, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
